Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes
Status:
Recruiting
Trial end date:
2026-05-31
Target enrollment:
Participant gender:
Summary
This study evaluates the change of insulin resistance and glucose metabolism of patients with
panniculitis associated acquired lipodystrophy syndrome and type 1 diabetes with the
treatment of cyclophosphamide.